Evaxion A (EVAX) Cash from Investing Activities (2020 - 2022)
Evaxion A posted quarterly Cash from Investing Activities of -$77000.0 for Q2 2022, up 90.63% year-on-year from -$40391.8 in Q2 2021, and up 51.57% on a QoQ basis from -$159000.0 in Q1 2022.
Evaxion A (EVAX) has 3 years of Cash from Investing Activities data on file, last reported at -$77000.0 in Q2 2022.
- For the quarter ending Q2 2022, Cash from Investing Activities rose 90.63% year-over-year to -$77000.0; the trailing twelve-month figure through Jun 2022 stood at -$2.2 million (down 57.25% YoY), and the FY2025 full-year result was -$14000.0, down 366.67% from the prior year.
- Cash from Investing Activities for Q2 2022 stood at -$77000.0, up from -$159000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$77000.0 in Q2 2022 and bottomed at -$1.2 million in Q3 2021.
- The 3-year median for Cash from Investing Activities is -$145000.0 (2020), against an average of -$359500.0.
- The widest annual swing landed in 2021, when Cash from Investing Activities plunged 780.15%; it then surged 90.63% in 2022.
- A 3-year view of Cash from Investing Activities shows it stood at -$131000.0 in 2020, then slumped by 780.15% to -$1.2 million in 2021, then surged by 93.32% to -$77000.0 in 2022.
- The last three Cash from Investing Activities figures came in at -$77000.0 (Q2 2022), -$159000.0 (Q1 2022), and -$1.2 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 172.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -77,000.00 |
| Jun 30, 2022 | -77,000.00 |
| Mar 31, 2022 | -159,000.00 |
| Mar 31, 2022 | -159,000.00 |
| Sep 30, 2021 | -1.15 Mn |
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | -822,000.00 |
| Jun 30, 2021 | -822,000.00 |
| Mar 31, 2021 | -327,000.00 |
| Mar 31, 2021 | -327,000.00 |
| Sep 30, 2020 | -131,000.00 |
| Sep 30, 2020 | -131,000.00 |
| Jun 30, 2020 | -126,000.00 |
| Jun 30, 2020 | -126,000.00 |
| Mar 31, 2020 | -81,000.00 |
| Mar 31, 2020 | -81,000.00 |